Inhibitor Therapeutics, Inc. (INTI)
Inhibitor Therapeutics, Inc. engages in the discovery, development, and commercialization of therapeutics for patients with cancer. It focuses on SUBA-Itraconazole, a patented, oral formulation of Itraconazole, for treatment of prostate and lung cancers. The company was founded on September 30, 1992 and is headquartered in Tampa, FL.
Address
4830 W. KENNEDY BLVD.
TAMPA, FL 33609
Founded
1992
Number of Employees
9
Website
http://www.inhibitortx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)